Director & Chief Executive Officer
Director & Chief Executive Officer at Spyre Therapeutics, Inc., filing insider transactions between 2026-08-03 and 2026-10-01.
| SEC ↗ |
| 2026-10-01 | SYRE | Sale | 100 | $93.91 | $9K | SEC ↗ |
| 2026-10-01 | SYRE | Sale | 2,683 | $90.10 | $242K | SEC ↗ |
| 2026-10-01 | SYRE | Sale | 600 | $89.14 | $53K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 400 | $89.07 | $36K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 2,500 | $86.36 | $216K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 3,700 | $88.06 | $326K | SEC ↗ |
| 2026-09-01 | SYRE | Sale | 8,400 | $87.15 | $732K | SEC ↗ |
| 2026-08-03 | SYRE | Sale | 1,392 | $96.82 | $135K | SEC ↗ |
| 2026-08-03 | SYRE | Sale | 800 | $93.97 | $75K | SEC ↗ |
| 2026-08-03 | SYRE | Sale | 7,157 | $95.10 | $681K | SEC ↗ |
| 2026-08-03 | SYRE | Sale | 5,635 | $95.93 | $541K | SEC ↗ |
| 2026-08-03 | SYRE | Sale | 16 | $97.46 | $2K | SEC ↗ |